Dublin, July 24, 2017 (GLOBE NEWSWIRE) — The “Global Polymerase Chain Reaction Market – Drivers, Restraints, Opportunities, Trends, and Forecasts: 2017-2023” report has been added to Research and Markets’ offering.

The global polymerase chain reaction market is estimated to witness a CAGR of 9.91% during the forecast period 2017-2023.

As more than two decades have passed since the evolution of PCR, the market is in a mature stage for standard PCR systems. In recent times, advances in technology have paved the way for the evolution of real-time PCR and digital PCR systems. Continuous technology advancements are making it more efficient and user-friendly, but the high cost of the instruments, servicing contracts, and reagents pose major challenges for the market, especially to the price-sensitive academics. Currently, the market players are involved in enhancing the capabilities of the PCR systems, and increasing its specificity and sensitivity.

The market is witnessing an emerging trend of digital and droplet digital PCR technology, which is sensitive and accurate than the traditional method.

The market is segmented into instruments, reagents & consumables, and software & services. Reagents hold the largest share of the global polymerase chain reaction market, and is expected to exhibit the fastest growth during the forecast period.

The increasing use of PCR in genetic and molecular analysis, the advent of digital PCR technology are the key factors driving the market. The high cost of the instrument, dearth of skilled labors, competing technologies, such as NGS and microarray and stringent government regulations are factors restricting the market growth.

Application Analysis:

The application of PCR is predominant in clinical diagnostics, life sciences, and others. The life sciences segment holds the largest share in the market. But the market for clinical diagnostics is expected to grow rapidly due to the increasing adoption of PCR systems for the diagnosis of diseases. The market is also witnessing various mergers, acquisitions, and collaborations among the top players, which is defining the future of the global polymerase chain reaction market.

End-users Analysis:

The end-users of PCR are hospitals, pharmaceutical & biotechnological companies, academics, and others (blood banks). Academics held a large market share in the PCR market in 2016. The demand for precise diagnosis of chronic diseases has increased in hospitals and diagnostic laboratories, which, in turn, will increase the growth rate of the global PCR market.

Key Players:

Thermo Fisher, Bio-Rad Laboratories, F. Hoffmann-La Roche, Abbott Laboratories, Merck KGaA, Becton Dickenson & company, Promega, Qiagen N.V., and Agilent Technologies are the key players in the market.

Key Topics Covered:

1 Industry Outlook
1.1 Industry Overview
1.2 Industry Trends
1.3 PEST Analysis

2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions

3 Market Snapshot
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Related Markets
3.3.1 Next Generation Sequencing
3.3.2 In-situ Hybridization
3.3.3 Microarray

4 Market Outlook
4.1 Market Definition
4.2 Importance of Polymerase Chain Reaction
4.2.1 Medical Applications
4.2.2 Infectious Disease Diagnosis
4.2.3 Molecular Biology Research
4.3 Market Segmentation
4.4 Porter 5(Five) Forces

5 Market Characteristics
5.1 Polymerase Chain Reaction Technology Types
5.1.1 Real-Time PCR/qPCR
5.1.2 Nested PCR
5.1.3 Reverse Transcription PCR
5.1.4 Digital PCR
5.1.5 Assembly PCR
5.1.6 Multiplex PCR
5.1.7 Hot Start PCR
5.1.8 Others
5.2 Evolution
5.3 Polymerase Chain Reaction Advantages
5.4 Polymerase Chain Reaction Disadvantages
5.5 Market Dynamics
5.5.1 Drivers Rising demand for PCR in genetic and molecular testing Expiry of key PCR patents Advent of digital PCR technology
5.5.2 Opportunities Growth of personalized medicines Growing applications in the fields of life sciences research and clinical diagnostics
5.5.3 Restraints Lack of skilled labor Competition from NGS and Microarray technology Stringent government regulations
5.6 DRO – Impact Analysis
5.7 Key Stakeholders

6 Products: Market Size and Analysis
6.1 Overview
6.2 Instruments
6.2.1 Standard PCR
6.2.2 Quantitative PCR/Real Time PCR
6.2.3 Digital PCR
6.3 Reagents and Consumables
6.4 Software and Services

7 Application: Market Size and Analysis
7.1 Overview
7.2 Clinical Diagnostics
7.3 Biomedical Research
7.4 Others

8 End-users: Market Size and Analysis
8.1 Overview
8.2 Hospitals and Laboratories
8.3 Pharmaceutical Companies
8.4 Academics
8.5 Others

9 Regions: Market Size and Analysis

10 Competitive Landscape
10.1 Overview

11 Vendor Profiles
11.1 Bio-Rad Laboratories
11.2 F. Hoffmann-La Roche Ltd.
11.3 Thermo Fisher Scientific Inc.
11.4 Abbott Laboratories
11.5 Agilent Technologies Inc.

12 Companies to Watch For
12.1 Becton Dickinson and Company
12.2 Merck KGaA
12.3 Danaher Corporation
12.4 Promega Corp.
12.5 QIAGEN N.V.

For more information about this report visit https://www.researchandmarkets.com/research/7bp6c8/global_polymerase


CONTACT: Research and Markets
         Laura Wood, Senior Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Infectious Disease Testing, Enzymes , Molecular Diagnostics